Published on
Apr 9, 2025
Imaging-Based Treatment Modifications Only Used in 15 Percent of Neoadjuvant Systemic Therapy Trials for Breast Cancer
How often are imaging modalities, such as mammography, breast magnetic resonance imaging (MRI) or ultrasound, utilized in clinical trial investigations to assess neoadjuvant systemic therapy (NST) for breast cancer? In a new systematic review, recently …
Source:
Diagnostic Imaging
-
Label Pending
